The Role

Moderna continues to expand its innovative mRNA platform, unlocking new applications across diseases and therapeutic areas. As the company advances its oncology pipeline, including a personalized mRNA therapy intismeran in collaboration with Merck, a Phase 2 off-the-shelf cancer therapy (mRNA-4359), and additional cancer antigen therapies (mRNA-4106 and mRNA-4203) entering Phase 1, this role will play a critical part in shaping portfolio decisions.

Moderna is seeking a Director of Strategic Forecasting to lead global revenue forecasting for its oncology portfolio, spanning early research through launch readiness. This high-impact individual contributor role sits within the Commercial organization and supports investment decisions, portfolio planning, and long-range forecasting for pipeline assets as well as operational US forecasting for intismeran.

This role partners closely with R&D, Commercial, F...